July 28, 2026 Soft exosuit helps people walk without bulky motors A 4.2-pound soft exosuit using artificial muscles instead of motors cut walking energy use by nearly 14% in treadmill tests with six adults.
July 28, 2026 Millions could gain easier access to popular peptides after FDA panel vote An FDA panel voted to recommend six peptides including BPC-157, TB-500, and KPV for compounding by licensed pharmacies instead of grey market vendors.
July 27, 2026 Woman wins massive settlement after bladder mistakenly removed during surgery for benign cyst A Maine jury awarded a woman $17 million after a routine surgery for a benign ovarian cyst ended with the accidental removal of her bladder.
July 27, 2026 Financial hardship may age the brain faster, researchers say in new study Chronic poverty over decades was linked to memory loss, slower processing speed and brain shrinkage, with strongest effects among men and APOE-ε4 carriers.
July 27, 2026 AI wearable watches you to predict what you need The iKairos AI wearable features an inward-facing camera and voice detection to anticipate your needs, raising significant privacy questions.
July 26, 2026 Self-dressing clothes could help older adults KAIST and Stanford researchers built soft robotic tubes into fabric that use air pressure to guide clothing into place in about 10 seconds flat.
July 25, 2026 Man who beat rare cancer celebrates by canoeing 2,000 miles with his dog Frank Carter, 67, and his dog Amos completed a 2,000-mile canoe trip down the Missouri River four years after CAR T-cell therapy cleared his lymphoma.
July 23, 2026 Microplastics detected in most heart attack patients' blood in startling new study Nearly 84% of severe heart attack patients had detectable microplastics in their coronary artery blood, with polyethylene found in 97% of cases.
July 22, 2026 Expert urges FDA panel to weigh 'real-world' safety data on peptides Dr. Alex Tatem, a board-certified urologist in Indiana, discusses why upcoming federal hearings on seven peptides were mandated and argues that years of patient use show a promising safety profile.
July 22, 2026 Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients A Johns Hopkins pancreatic cancer vaccine triggered immune responses in 90% of high-risk participants, with some cysts shrinking after vaccination.